KMT2A and breast carcinoma: For example, CCL20, increased in serum from animals with MLL tumors, has been shown to be highly expressed in breast cancer models, and inhibition of CCL20 expression or depletion of the CCL20 receptor gene (Ccr6) reduce macrophage infiltration in xenografts39,40.